Literature DB >> 19597644

Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.

Selvi Palasubramaniam1, Sekaran Muniandy, Parasakthi Navaratnam.   

Abstract

BACKGROUND AND
PURPOSE: In addition to beta-lactamase production, loss of porins confers resistance to extended-spectrum beta-lactams in Klebsiella pneumoniae and Escherichia coli infection. This study describes the detection of SHV-12 extended-spectrum beta-lactamase (ESBL) subtype and the loss of OmpK35 porin in 4 strains of K. pneumoniae and E. coli.
METHODS: Isoelectric focusing was performed to detect beta-lactamases in 4 strains of K. pneumoniae and E. coli. The presence of the SHV gene in the 4 isolates was characterized by polymerase chain reaction, DNA sequencing, and DNA hybridization. Loss of porin in these strains was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western blot analysis.
RESULTS: The strains of K. pneumoniae and E. coli were confirmed to be ESBL producers and were resistant to cefoxitin, with minimal inhibitory concentration values of 512 microg/mL. All 4 strains had beta-lactamases with an isoelectric value of 8.2. The SHV gene from these strains was characterized to be the SHV-12 subtype and was plasmid-borne. The deduced amino acid sequence showed that the SHV-12 beta-lactamase was a derivative of the more common ESBL, SHV-5 subtype. All the strains showed absence of the OmpK35 porin.
CONCLUSION: Resistance of the strains towards extended-spectrum beta-lactams was a result of a dual-mechanism - the production of SHV-12 enzymes and loss of the OmpK35 porin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597644

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

1.  Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.

Authors:  Yu-Kuo Tsai; Chang-Phone Fung; Jung-Chung Lin; Jiun-Han Chen; Feng-Yee Chang; Te-Li Chen; L Kristopher Siu
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.

Authors:  Raphaël Lepeule; Etienne Ruppé; Patrick Le; Laurent Massias; Françoise Chau; Amandine Nucci; Agnès Lefort; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

3.  Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.

Authors:  H Guet-Revillet; A Emirian; M Groh; B Nebbad-Lechani; E Weiss; O Join-Lambert; E Bille; V Jullien; J R Zahar
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

4.  Molecular Analysis of Antibiotic Resistance Determinants and Plasmids in Malaysian Isolates of Multidrug Resistant Klebsiella pneumoniae.

Authors:  Farah Al-Marzooq; Mohd Yasim Mohd Yusof; Sun Tee Tay
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

Review 5.  The janus facet of nanomaterials.

Authors:  Julianna Kardos; Katalin Jemnitz; István Jablonkai; Attila Bóta; Zoltán Varga; Júlia Visy; László Héja
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

6.  Analysis of diverse β-lactamases presenting high-level resistance in association with OmpK35 and OmpK36 porins in ESBL-producing Klebsiella pneumoniae.

Authors:  Hasan Ejaz
Journal:  Saudi J Biol Sci       Date:  2022-02-25       Impact factor: 4.052

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.